Abstract

Ginkgo biloba L., a “living fossil” and medicinal plant, is a well-known rich source of bioactive flavonoids. The molecular mechanism underlying the biosynthesis of flavonoid glucosides, the predominant flavonoids in G. biloba, remains unclear. To better understand flavonoid glucosylation in G. biloba, we generated a transcriptomic dataset of G. biloba leaf tissue by high-throughput RNA sequencing. We identified 25 putative UDP-glycosyltransferase (UGT) unigenes that are potentially involved in the flavonoid glycosylation. Among them, we successfully isolated and expressed eight UGT genes in Escherichia coli, and found that recombinant UGT716A1 protein was active toward broad range of flavonoid/phenylpropanoid substrates. In particular, we discovered the first recombinant UGT protein, UGT716A1 from G. biloba, possessing unique activity toward flavanol gallates that have been extensively documented to have significant bioactivity relating to human health. UGT716A1 expression level paralleled the flavonoid distribution pattern in G. biloba. Ectopic over-expression of UGT716A1 in Arabidopsis thaliana led to increased accumulation of several flavonol glucosides. Identification and comparison of the in vitro enzymatic activity of UGT716A1 homologs revealed a UGT from the primitive land species Physcomitrella patens also showed broader substrate spectrum than those from higher plants A. thaliana, Vitis vinifera, and Medicago truncatula. The characterization of UGT716A1 from G. biloba bridges a gap in the evolutionary history of UGTs in gymnosperms. We also discuss the implication of UGT716A1 for biosynthesis, evolution, and bioengineering of diverse glucosylated flavonoids.

Highlights

  • Ginkgo biloba has existed on earth for 200 million years and is called a “living fossil”

  • To characterize genes involved in flavonoid biosynthesis in G. biloba, in particular UGT genes, we performed transcriptome sequencing with leaf tissue

  • Among the 14 functional groups identified by KOG classification, secondary metabolites biosynthesis, transport, and catabolism counted for 3.8% (Supplementary Figure S1B)

Read more

Summary

Introduction

Ginkgo biloba has existed on earth for 200 million years and is called a “living fossil”. G. biloba has been recorded in clinical practice for more than four centuries, since the Ming Dynasty, in the Compendium of Materia Medica (Li and Luo, 2004). G. biloba leaf tissue accumulates abundant secondary metabolites, including flavonoids and terpenoids. Multi-substrate UDP-Glucosyltransferase Gene from Ginkgo (van Beek, 2002; van Beek and Montoro, 2009). EGb761, the standardized extract of G. biloba leaf, contains about 24% flavonol glycosides, 20% non-flavonol glycosides, 7% proanthocyanidins, 2% flavanols, and 6% terpenoids (van Beek and Montoro, 2009). More than 60 different flavonoids have been identified in G. biloba, and the majority of them are glycosylated (Liu et al, 2015)

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call